3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Hematologic Neoplasms
1
Interventions
Cyclophosphamide
222
pembrolizumab
199
Carboplatin
173
Cisplatin
168
Gemcitabine
167
Paclitaxel
153
Docetaxel
139
Rituximab
137
Bevacizumab
137
Radiotherapy
136
Dexamethasone
126
Nivolumab
125
Capecitabine
103
fludarabine
102
Pemetrexed
92
fludarabine phosphate
91
Fluorouracil
91
Doxorubicin
85
Oxaliplatin
79
Etoposide
77
Cytarabine
77
Bortezomib
76
Erlotinib Hydrochloride
74
Leucovorin
72
Filgrastim
68
Lenalidomide
67
Calcium Dobesilate
66
Irinotecan
65
atezolizumab
62
Radiation
61
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Has results
×
Health Promotion
×
Clear all
NCT04081298
2023-07-03
MiVSEEV
Fred Hutchinson Cancer Center
Phase NA
Terminated
20 enrolled
34 charts